The arginine metabolism and its deprivation in cancer therapy
Cancer Letters · 2025-06 · 620 · 217680
DOI: 10.1016/j.canlet.2025.217680 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-06. Verfasst von Tiejun Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, Prince of Wales Hospital…. Hauptthemen laut MEDLINE: Arginine, Neoplasms. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese University of Hong Kong, National Natural Science Foundation of China.
Abstract (Originalsprache)
Arginine deprivation has emerged as a promising therapeutic strategy in cancer treatment due to the auxotrophy of certain tumors. Many cancers, such as pancreatic, colorectal, and hepatocellular carcinoma, exhibit downregulated argininosuccinate synthetase, making them reliant on external arginine sources. This dependency allows targeted therapies that deplete arginine, inhibiting tumor growth while sparing normal cells. Arginine is crucial for various cellular processes, including protein synthesis and immune function. Its deprivation affects both tumor metabolism and immune responses, potentially enhancing cancer therapy. Studies have explored using enzymes like arginine deiminase and arginase, often modified for increased stability and reduced immunogenicity, to effectively lower arginine levels in the tumor microenvironment. These approaches show promise, particularly in tumors with low argininosuccinate synthetase expression. However, the impact on immune cells and the potential for resistance highlight the need for further research. Combining arginine deprivation with other treatments might improve outcomes, offering a novel approach to combat arginine-dependent cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, Prince of Wales Hospital, The Chinese University of Hong Kong, China.
- Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, Prince of Wales Hospital, The Chinese University of Hong Kong, China; Institute of Digestive D…
- Institute of Digestive Disease, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, China; Department of Medicine and Therapeutics, The Chinese Univer…
- Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases (TMBJ), School of Chinese Medicine, Hong Kong Baptist University, China.
- Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, Prince of Wales Hospital, The Chinese University of Hong Kong, China. Electronic address: anna…
Förderung
- Chinese University of Hong Kong
- National Natural Science Foundation of China
Zitieren
APA
Feng, T., Xie, F., Lyu, Y., Yu, P., Chen, B., Yu, J., Zhang, G., To, K. F., Tsang, C. M., & Kang, W. (2025). The arginine metabolism and its deprivation in cancer therapy. Cancer Letters, 620, 217680. https://doi.org/10.1016/j.canlet.2025.217680
Vancouver
Feng T, Xie F, Lyu Y, Yu P, Chen B, Yu J, et al. The arginine metabolism and its deprivation in cancer therapy. Cancer Letters. 2025;620:217680. doi:10.1016/j.canlet.2025.217680
BibTeX
@article{Feng2025,
author = {Feng, Tiejun and Xie, Fuda and Lyu, Yang and Yu, Peiyao and Chen, Bonan and Yu, Jun and Zhang, Ge and To, Ka Fai and Tsang, Chi Man and Kang, Wei},
title = {The arginine metabolism and its deprivation in cancer therapy},
journal = {Cancer Letters},
year = {2025},
volume = {620},
pages = {217680},
doi = {10.1016/j.canlet.2025.217680}
}
EUVIMED